Webinars

Streamlining biotech production at Fujifilm Diosynth Biotechnologies

159 views
November 11, 2025 digital supply chain

Discover how Fujifilm Diosynth Biotechnologies is transforming its complex biotech production process with digital tools, modular systems, and end-to-end data. Learn how their journey reduces lead times, enhances efficiency, and engages employees in reshaping the way medicines reach patients faster.

Overview of the digital transformation
Fujifilm Diosynth Biotechnologies has embarked on a digital transformation journey to tackle the challenges of producing medicines in a highly regulated, 24-7 environment. By focusing on a clear digital vision, the company is reducing lead times, streamlining production, and making critical data accessible to all stakeholders across the supply chain.

Key elements of the transformation
The transformation centers on four core elements: one-click tech transfer, modular and digital manufacturing, no-touch release, and data at your fingertips. These elements work together to standardize processes, integrate digital systems, and allow skilled operators to focus on high-value tasks, while automation handles repetitive activities efficiently.

Impact on people and processes
Beyond technology, the transformation emphasizes employee engagement and culture. By involving shop floor employees and quality teams, Fujifilm Diosynth Biotechnologies ensures that changes are adopted smoothly. This approach builds a sustainable way of working, reduces manual effort, and creates a more efficient, future-ready workplace.

Lessons and takeaways
Key takeaways from the journey include starting with business value, implementing standards early, and avoiding overreliance on specific tools. The process is long-term and iterative, requiring empathy, adaptability, and a focus on tangible results. The company demonstrates that digital transformation is as much about people as it is about technology.